Join the Depression group to help and get support from people like you.
Depression News (Page 26)
Related terms: Major Depression, Unipolar Depression
Peer Victimization, Suicidality Linked to Recurrent Headaches in Teens
THURSDAY, Aug. 3, 2023 – Peer victimization and suicidality may be associated with higher headache frequency in adolescents with recurrent headaches, according to a study published online Aug. 2 in...
Bullying Could Help Bring on Headaches for Teens
THURSDAY, Aug. 3, 2023 – So, your high schooler has been complaining of headaches. Should you worry? Maybe, claims new research that finds bullying and suicidal thoughts are both linked to more...
Zuranolone Pill to Counter Postpartum Depression Looks Good in Trial and May Gain FDA Approval
WEDNESDAY, Aug. 2, 2023 – All eyes are on the U.S. Food and Drug Administration this week as the agency weighs approval of a new pill that may quickly treat and ease severe postpartum depression....
Prevalence of Neuropsychiatric Symptoms Up for Autoimmune Rheumatic Disease
TUESDAY, Aug. 1, 2023 – The prevalence of all self-reported neuropsychiatric symptoms is significantly higher in those with systemic autoimmune rheumatic diseases (SARDs) versus controls, according...
Summer Jobs Give Kids More Than a Paycheck
SATURDAY, July 29, 2023 – Summer jobs can give teens valuable life experience that help them transition to adulthood – not just a paycheck, according to the American Academy of Pediatrics. Benefits...
Your Teen & Social Media: Experts Offer Tips to Parents
MONDAY, July 31, 2023 – When parents meet U.S. Surgeon General Dr. Vivek Murthy, one concern comes up time after time. "The most common question parents ask me is: 'Is social media safe for my...
With New Proposed Rules, Biden Administration Pushes Insurers to Boost Mental Health Coverage
WEDNESDAY, July 26, 2023 – President Joe Biden announced Tuesday that his administration is seeking new rules to push insurance companies to increase coverage of mental health treatment. The new...
Over Half of People With Autoimmune Conditions Suffer Depression, Anxiety
WEDNESDAY, July 26, 2023 – More than half of all patients with autoimmune diseases also suffer from depression and anxiety – but most are never asked about their mental health, a new study finds....
With New Proposed Rules, Biden Administration Pushes Insurers to Boost Mental Health Coverage
WEDNESDAY, July 26, 2023 – President Joe Biden announced Tuesday that his administration is seeking new rules to push insurance companies to increase coverage of mental health treatment. The new...
Risk for Incident Dementia Increased With Diagnosed Depression
MONDAY, July 24, 2023 – Men and women with diagnosed depression have an increased risk for dementia, according to a study published online July 24 in JAMA Neurology. Holly Elser, M.D., Ph.D., from...
FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults
Auvelity is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to placebo starting at one week11-4...
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for Caplyta (lumateperone) for Specific Patient Populations
Caplyta label now includes dosage recommendations for specific patient populations; those with moderate or severe hepatic impairment and patients who are concomitantly taking moderate or strong...
FDA Approves Spravato (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
TITUSVILLE, N.J. – (August 3, 2020) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug ...
FDA Approves Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression
DUBLIN and BUDAPEST, Hungary, May 28, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has approved a...
FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
March 19, 2019 -- The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This ...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Major Depressive Disorder, Dysthymia, Sexual Dysfunction, SSRI Induced, Seasonal Affective Disorder, Postpartum Depression
Related drug support groups
Lexapro, tramadol, Zoloft, sertraline, Wellbutrin, Cymbalta, trazodone, Prozac, Effexor, view more... citalopram, escitalopram, bupropion, mirtazapine, Abilify, amitriptyline, Celexa, venlafaxine, fluoxetine, Paxil, alprazolam, Effexor XR, Pristiq, lithium, Wellbutrin XL, Viibryd, duloxetine, lamotrigine, quetiapine, Remeron, nortriptyline, Wellbutrin SR, methylphenidate, paroxetine, olanzapine, risperidone, Zyprexa, modafinil, aripiprazole, Elavil, Rexulti, clomipramine, doxepin, Seroquel XR, ketamine, valerian, fluvoxamine, niacin, desvenlafaxine